Back to MW MARSHALL WACE, LLP

CRNXCRNX
Showing 5 of 16 quarters

Position history for MWMARSHALL WACE, LLP's holdings in CRINETICS PHARMACEUTICALS IN

MARSHALL WACE, LLP holds 1.1M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $42.2M as of 2026-Q2. The position was increased (+64.7% shares). CRNX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$42.2M

Current Shares

1.1M

Total Value Change

+$42.2M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+64.7%
$42.2M0.0%$37.42
43
2026-Q1
New
684,108
-
$24.8M0.0%$36.32
40
2025-Q2
Exited
0
-100.0%
$00.0%$28.76
0
2025-Q1
New
9,182
-
$307,9640.0%$33.54
32
2024-Q3
Exited
0
-100.0%
$00.0%$51.10
0

Other major holders of CRNX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used